Physician profile
Rodney Chou
NPI 1750385480
$1,267.61
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $413 · 2021: $575 · 2023: $16.42 · 2024: $71.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $300.33 | 2019-2021 | |
| Si-Bone, INC. | $239.40 | 2021 | |
| Collegium Pharmaceutical, INC. | $167.09 | 2019-2021 | |
| Medtronic, INC. | $118.29 | 2021 | |
| Medtronic USA, INC. | $116.19 | 2020 | |
| Scilex Pharmaceuticals INC. | $68.92 | 2021-2024 | |
| Arbor Pharmaceuticals, INC. | $66.34 | 2019-2021 | |
| Boston Scientific Corporation | $49.88 | 2019-2024 | |
| Flowonix Medical Incorporated | $38.12 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.50 | 2019-2020 | |
| Tersera Therapeutics LLC | $16.42 | 2023 | Prialt |
| Abbott Laboratories | $14.38 | 2021 | |
| Assertio Therapeutics, INC. | $13.78 | 2019 | |
| Shionogi INC | $11.60 | 2019 | |
| Ibsa Pharma INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.